These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 26781467)

  • 1. TUFM downregulation induces epithelial-mesenchymal transition and invasion in lung cancer cells via a mechanism involving AMPK-GSK3β signaling.
    He K; Guo X; Liu Y; Li J; Hu Y; Wang D; Song J
    Cell Mol Life Sci; 2016 May; 73(10):2105-21. PubMed ID: 26781467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial dysfunction induces the invasive phenotype, and cell migration and invasion, through the induction of AKT and AMPK pathways in lung cancer cells.
    Han SY; Jeong YJ; Choi Y; Hwang SK; Bae YS; Chang YC
    Int J Mol Med; 2018 Sep; 42(3):1644-1652. PubMed ID: 29916527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Succinate dehydrogenase 5 (SDH5) regulates glycogen synthase kinase 3β-β-catenin-mediated lung cancer metastasis.
    Liu J; Gao L; Zhang H; Wang D; Wang M; Zhu J; Pang C; Wang C
    J Biol Chem; 2013 Oct; 288(41):29965-73. PubMed ID: 23983127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptin-induced epithelial-mesenchymal transition in breast cancer cells requires β-catenin activation via Akt/GSK3- and MTA1/Wnt1 protein-dependent pathways.
    Yan D; Avtanski D; Saxena NK; Sharma D
    J Biol Chem; 2012 Mar; 287(11):8598-612. PubMed ID: 22270359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
    Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y
    Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTEN inactivation induces epithelial-mesenchymal transition and metastasis by intranuclear translocation of β-catenin and snail/slug in non-small cell lung carcinoma cells.
    Perumal E; So Youn K; Sun S; Seung-Hyun J; Suji M; Jieying L; Yeun-Jun C
    Lung Cancer; 2019 Apr; 130():25-34. PubMed ID: 30885348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mdig suppresses epithelial-mesenchymal transition and inhibits the invasion and metastasis of non‑small cell lung cancer via regulating GSK-3β/β-catenin signaling.
    Geng F; Jiang Z; Song X; Zhou H; Zhao H
    Int J Oncol; 2017 Dec; 51(6):1898-1908. PubMed ID: 29039479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
    Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MCUR1 facilitates epithelial-mesenchymal transition and metastasis via the mitochondrial calcium dependent ROS/Nrf2/Notch pathway in hepatocellular carcinoma.
    Jin M; Wang J; Ji X; Cao H; Zhu J; Chen Y; Yang J; Zhao Z; Ren T; Xing J
    J Exp Clin Cancer Res; 2019 Mar; 38(1):136. PubMed ID: 30909929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of tumor suppressing STF cDNA 3 promotes epithelial-mesenchymal transition and tumor metastasis of osteosarcoma by the Wnt/GSK-3β/β-catenin/Snail signaling pathway.
    Lv YF; Dai H; Yan GN; Meng G; Zhang X; Guo QN
    Cancer Lett; 2016 Apr; 373(2):164-73. PubMed ID: 26845447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GSK3β controls epithelial-mesenchymal transition and tumor metastasis by CHIP-mediated degradation of Slug.
    Kao SH; Wang WL; Chen CY; Chang YL; Wu YY; Wang YT; Wang SP; Nesvizhskii AI; Chen YJ; Hong TM; Yang PC
    Oncogene; 2014 Jun; 33(24):3172-82. PubMed ID: 23851495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha.
    Jiang YG; Luo Y; He DL; Li X; Zhang LL; Peng T; Li MC; Lin YH
    Int J Urol; 2007 Nov; 14(11):1034-9. PubMed ID: 17956532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TUFM is involved in Alzheimer's disease-like pathologies that are associated with ROS.
    Zhong BR; Zhou GF; Song L; Wen QX; Deng XJ; Ma YL; Hu LT; Chen GJ
    FASEB J; 2021 May; 35(5):e21445. PubMed ID: 33774866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells.
    Rosanò L; Spinella F; Di Castro V; Nicotra MR; Dedhar S; de Herreros AG; Natali PG; Bagnato A
    Cancer Res; 2005 Dec; 65(24):11649-57. PubMed ID: 16357176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin.
    Luo M; Hou L; Li J; Shao S; Huang S; Meng D; Liu L; Feng L; Xia P; Qin T; Zhao X
    Cancer Lett; 2016 Apr; 373(1):1-11. PubMed ID: 26805761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ING5 inhibits lung cancer invasion and epithelial-mesenchymal transition by inhibiting the WNT/β-catenin pathway.
    Liu XL; Meng J; Zhang XT; Liang XH; Zhang F; Zhao GR; Zhang T
    Thorac Cancer; 2019 Apr; 10(4):848-855. PubMed ID: 30810286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
    Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
    Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocyte elevated gene-1(AEG-1) induces epithelial-mesenchymal transition in lung cancer through activating Wnt/β-catenin signaling.
    He W; He S; Wang Z; Shen H; Fang W; Zhang Y; Qian W; Lin M; Yuan J; Wang J; Huang W; Wang L; Ke Z
    BMC Cancer; 2015 Mar; 15():107. PubMed ID: 25880337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLE1 promotes EMT in A549 lung cancer cells through suppression of E-cadherin.
    Yao X; Ireland SK; Pham T; Temple B; Chen R; Raj MH; Biliran H
    Biochem Biophys Res Commun; 2014 Dec; 455(3-4):277-84. PubMed ID: 25446087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNF8 promotes epithelial-mesenchymal transition of breast cancer cells.
    Kuang J; Li L; Guo L; Su Y; Wang Y; Xu Y; Wang X; Meng S; Lei L; Xu L; Shao G
    J Exp Clin Cancer Res; 2016 Jun; 35(1):88. PubMed ID: 27259701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.